APA (7th ed.) Citation

WS, O., S, V., Y, A. H., P, M., AB, C., J, B., . . . R, N. (2026). Chemo-Nonresponsive Telangiectatic Osteosarcoma With Oligometastatic Recurrence Managed With Multimodality Therapy Including Stereotactic Ablative Body Radiotherapy (SABR): A Case Report With a Pathologic Treatment Effect. Cureus, 18(3), e106242. https://doi.org/10.7759/cureus.106242

Chicago Style (17th ed.) Citation

WS, Orr, et al. "Chemo-Nonresponsive Telangiectatic Osteosarcoma With Oligometastatic Recurrence Managed With Multimodality Therapy Including Stereotactic Ablative Body Radiotherapy (SABR): A Case Report With a Pathologic Treatment Effect." Cureus 18, no. 3 (2026): e106242. https://doi.org/10.7759/cureus.106242.

MLA (9th ed.) Citation

WS, Orr, et al. "Chemo-Nonresponsive Telangiectatic Osteosarcoma With Oligometastatic Recurrence Managed With Multimodality Therapy Including Stereotactic Ablative Body Radiotherapy (SABR): A Case Report With a Pathologic Treatment Effect." Cureus, vol. 18, no. 3, 2026, p. e106242, https://doi.org/10.7759/cureus.106242.